Please login to the form below
Infographic: Orphan drug market
A visual guide to the orphan drug and rare disease market for pharma
This infographic provides some key details about the orphan drug market for the pharma industry.
For a more detailed look at market access for orphan drugs read 'Orphan indication? No easy access'.
COVID-19 Updates and Daily News
Featured jobs
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
-
Senior Health Psychologist, London
-
Highly competitive salary
-
Consultant Dermatologist (Freelance)
-
£110-180ph
- Senior Account Executive, Medical/ Brand Communications, London
-
Highly competitive salary
-
Head of Health Psychology, London
-
Highly competitive salary
- Scientists discover new approach to treat brain tumours
- Boehringer Ingelheim’s pulmonary fibrosis treatment produces promising phase 2 data
- BMA appoints two internal candidates to share the role of chief executive officer
- Taking a holistic approach to patient care
- Almirall and Evotec team up in multi-target dermatology alliance
- AstraZeneca and UK-based biotech company RQ BIO sign licencing agreement
- EMA accepts Valneva’s marketing authorisation application for COVID-19 vaccine
- UICC launches global ATOM Coalition to increase access to essential cancer medicines
- Innovative Medical Solutions for Postponing and Undoing Age-Related Disease
- Almirall and Evotec team up in multi-target dermatology alliance
- Moderna wins Prix Galien UK Award for best biotechnology product
- Why testing shouldn't be confined to the lab
- BioXcel Therapeutics begins phase 3 trial for acute agitation in Alzheimer’s patients
- Celebrating the power of knowledge on International Thalassaemia Day 2022
- Rare Disease Day – looking to the future with hope
- BMA appoints two internal candidates to share the role of chief executive officer
- Bristol Myers Squibb releases positive trial results for plaque psoriasis treatment
- Eli Lilly and Incyte's Olumiant approved by FDA for hospitalised COVID-19 patients
